File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1–7) Axis in Mice

TitleFGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1–7) Axis in Mice
Authors
KeywordsACE2
angiotensin II
angiotensin-(1–7)
FGF21
hypertension
Issue Date2018
PublisherCell Press. The Journal's web site is located at http://www.elsevier.com/locate/cellmet
Citation
Cell Metabolism, 2018, v. 27 n. 6, p. 1323-1337.e5 How to Cite?
AbstractFibroblast growth factor 21 (FGF21) is a metabolic hormone with pleiotropic effects on glucose and lipid metabolism and insulin sensitivity. However, the role of FGF21 in hypertension remains elusive. Here we show that FGF21 deficiency significantly exacerbates angiotensin II-induced hypertension and vascular dysfunction, whereas such negative effects are reversed by replenishment of FGF21. Mechanistically, FGF21 acts on adipocytes and renal cells to promote induction of angiotensin-converting enzyme 2 (ACE2), which in turn converts angiotensin II to angiotensin-(1–7), then inhibits hypertension and reverses vascular damage. In addition, ACE2 deficiency strikingly abrogates these beneficial effects of FGF21 in mice, including alleviation of angiotensin II-associated hypertension and vascular damage. Otherwise, pharmaceutical inhibition of angiotensin-(1–7) attenuates the protective effect of FGF21 on angiotensin II-induced vascular dysfunction, but not on hypertension. Thus, FGF21 protects against angiotensin II-induced hypertension and vascular impairment by activation of the ACE2/angiotensin-(1–7) axis via fine-tuning the multi-organ crosstalk between liver, adipose tissue, kidney, and blood vessels.
Persistent Identifierhttp://hdl.handle.net/10722/258643
ISSN
2023 Impact Factor: 27.7
2023 SCImago Journal Rankings: 11.406
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorPan, X-
dc.contributor.authorShao, Y-
dc.contributor.authorWu, F-
dc.contributor.authorWang, Y-
dc.contributor.authorXiong, R-
dc.contributor.authorZheng, J-
dc.contributor.authorTian, H-
dc.contributor.authorWang, B-
dc.contributor.authorWang, Y-
dc.contributor.authorZhang, Y-
dc.contributor.authorHan, Z-
dc.contributor.authorQu, A-
dc.contributor.authorXu, H-
dc.contributor.authorLu, A-
dc.contributor.authorYang, T-
dc.contributor.authorLi, X-
dc.contributor.authorXu, A-
dc.contributor.authorDu, J-
dc.contributor.authorLin, Z-
dc.date.accessioned2018-08-22T01:41:44Z-
dc.date.available2018-08-22T01:41:44Z-
dc.date.issued2018-
dc.identifier.citationCell Metabolism, 2018, v. 27 n. 6, p. 1323-1337.e5-
dc.identifier.issn1550-4131-
dc.identifier.urihttp://hdl.handle.net/10722/258643-
dc.description.abstractFibroblast growth factor 21 (FGF21) is a metabolic hormone with pleiotropic effects on glucose and lipid metabolism and insulin sensitivity. However, the role of FGF21 in hypertension remains elusive. Here we show that FGF21 deficiency significantly exacerbates angiotensin II-induced hypertension and vascular dysfunction, whereas such negative effects are reversed by replenishment of FGF21. Mechanistically, FGF21 acts on adipocytes and renal cells to promote induction of angiotensin-converting enzyme 2 (ACE2), which in turn converts angiotensin II to angiotensin-(1–7), then inhibits hypertension and reverses vascular damage. In addition, ACE2 deficiency strikingly abrogates these beneficial effects of FGF21 in mice, including alleviation of angiotensin II-associated hypertension and vascular damage. Otherwise, pharmaceutical inhibition of angiotensin-(1–7) attenuates the protective effect of FGF21 on angiotensin II-induced vascular dysfunction, but not on hypertension. Thus, FGF21 protects against angiotensin II-induced hypertension and vascular impairment by activation of the ACE2/angiotensin-(1–7) axis via fine-tuning the multi-organ crosstalk between liver, adipose tissue, kidney, and blood vessels.-
dc.languageeng-
dc.publisherCell Press. The Journal's web site is located at http://www.elsevier.com/locate/cellmet-
dc.relation.ispartofCell Metabolism-
dc.subjectACE2-
dc.subjectangiotensin II-
dc.subjectangiotensin-(1–7)-
dc.subjectFGF21-
dc.subjecthypertension-
dc.titleFGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1–7) Axis in Mice-
dc.typeArticle-
dc.identifier.emailWang, B: baile612@hku.hk-
dc.identifier.emailXu, A: amxu@hkucc.hku.hk-
dc.identifier.authorityXu, A=rp00485-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1016/j.cmet.2018.04.002-
dc.identifier.pmid29706566-
dc.identifier.scopuseid_2-s2.0-85046122599-
dc.identifier.hkuros286558-
dc.identifier.volume27-
dc.identifier.issue6-
dc.identifier.spage1323-
dc.identifier.epage1337.e5-
dc.identifier.isiWOS:000434480000017-
dc.publisher.placeUnited States-
dc.identifier.issnl1550-4131-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats